Results 41 to 50 of about 32,807 (303)

Dopaminergic agonist bromocriptin in treatment of diabetes mellitus type 2

Ожирение и метаболизм, 2011
Bromocriptine is a sympatholytic agonist of dopamine receptors, which is now proposed for treatment of type 2 diabetes mellitus. In animal studies bromocriptine elevates the decreased levels of dopamine in hypothalamus and blocks excessive sympathetic ...
O A Gerasimenko, E Pigarova, L K Dzeranova   +2 more
doaj   +1 more source

Severe Hypoglycemia Due To the Administration of Bromocriptine in a Non-Diabetic Patient: A Case Study

Case Reports in Clinical Practice, 2020
The patient was a 24-year-old man with persistent vegetative state following severe traumatic brain injury due to a car accident, who was referred to the emergency department with a generalized tonic-clonic seizure due to severe hypoglycemia. The patient
Saeed Choobkar, Samad Nazarpoor, Mojgan kaviani   +2 more
doaj   +1 more source

The mode of action of bromocriptine [PDF]

FEBS Letters, 1981
1. Introduction Bromocriptine, an ergot alkaloid and dopamine agonist, is the treatment of choice for the induction of ovulation and pregnancy in cases of infertility due to both functional and organic hyperprolactinemia, the latter being due to prolactin secreting pituitary adenomas.
D. Weinstein, Joseph G. Schenker, R. Folman, J.H. Slonim, Avraham Hochberg, Nathan de-Groot, I. Gloger   +6 more
openaire   +3 more sources

Bromocriptine for the Treatment of Peripartum Cardiomyopathy.

Cardiac failure review, 2018
Peripartum cardiomyopathy (PPCM) is a life-threatening, pregnancy-associated heart disease that develops towards the end of pregnancy or in the first months following delivery in previously healthy women.
T. Koenig, J. Bauersachs, D. Hilfiker-Kleiner   +2 more
semanticscholar   +1 more source

Bromocriptine mesylate: Food and Drug Administration approved new approach in therapy of non-insulin dependant diabetes mellitus with poor glycemic control

Journal of Pharmacy and Bioallied Sciences, 2010
Food and Drug Administration (FDA) approved bromocriptine mesylate, a quick release formulation, 0.8 mg tablets, as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Yogendra Keche
doaj   +1 more source

Repositioning Dopamine D2 Receptor Agonist Bromocriptine to Enhance Docetaxel Chemotherapy and Treat Bone Metastatic Prostate Cancer

Molecular Cancer Therapeutics, 2018
Docetaxel resistance remains a major obstacle in the treatment of prostate cancer bone metastasis. In this study, we demonstrate that the dopamine D2 receptor (DRD2) agonist bromocriptine effectively enhances docetaxel efficacy and suppresses skeletal ...
Yang Yang, K. Mamouni, Xin Li, Yanhua Chen, S. Kavuri, Yuhong Du, H. Fu, O. Kucuk, Daqing Wu   +8 more
semanticscholar   +1 more source

Impact of ergot alkaloid and steroidal implant on whole-body protein turnover and expression of mTOR pathway proteins in muscle of cattle

Frontiers in Veterinary Science, 2023
IntroductionHolstein steers (n = 32) were used to determine if the ergot analog, bromocriptine decreases muscle protein synthesis through inhibitory action on the mTOR pathway via a direct effect on signal proteins, and if these negative effects can be ...
Taylor D. Ferguson, Caroline M. M. Loos, Eric S. Vanzant, Kristine L. Urschel, James L. Klotz, Kyle R. McLeod   +5 more
doaj   +1 more source

Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy [PDF]

, 2016
No abstract ...
Arrigo, Biteker, Blauwet, Brignole, Burkhoff, Cecconi, Duncker, Elkayam, Ersbøll, Fett, Fett, Forster, Gevaert, Haghikia, Haghikia, Haghikia, Hilfiker-Kleiner, Hilfiker-Kleiner, Hilfiker-Kleiner, Hilfiker-Kleiner, Kao, Labbene, Levy, Maisch, Masip, McNamara, Mebazaa, Mebazaa, Miller, Mouquet, Napp, Neumann, O'Connor, Patten, Pillarisetti, Ponikowski, Rasmusson, Regitz-Zagrosek, Schroeter, Seyfarth, Slaughter, Sliwa, Sliwa, Sliwa, Stapel, Strueber, Thiele, Thiele, Tibazarwa   +48 more
core   +4 more sources

Incidence of heart valve disease in women treated with the ergot-derived dopamine agonist bromocriptine

BMC Cardiovascular Disorders, 2021
Background Ergot-derived dopamine agonists are thought to induce fibrotic changes in cardiac valve leaflets. We sought to determine the incidence of heart valve disease in women treated with bromocriptine compared with age and sex matched controls from ...
Marianne F. Clausen, Rasmus Rørth, Christian Torp-Pedersen, Lucas Malta Westergaard, Peter E. Weeke, Gunnar Gislason, Lars Køber, Emil Fosbøl, Søren Lund Kristensen   +8 more
doaj   +1 more source

Prolactin [PDF]

, 1977
During an oral glucose tolerance test (OGTT) glucose and insulin levels were measured in 26 patients with prolactin-producing pituitary tumours without growth hormone excess.
A. Renauld, A. Weissmann, A.C. Herrington, A.J. Lostroh, B. Winkler, C.N. Hales, E. Cerasi, E.E. McGarry, F.H. Schmidt, I.B. Rathgeb, J. Tourniaire, J.D. Manns, K. von Werder, K. Werder von, K. Werder von, M. M. C. Landgraf-Leurs, M.O. Thorner, M.W. Sinkoff, P. Berle, P. C. Scriba, R. Hörl, R. Landgraf, R. Landgraf, R.C. Bodo De, Y.N. Sinha   +24 more
core   +1 more source